Fidelity Investments
XGN icon

Fidelity Investments’s Exagen XGN Stock Holding History

Fidelity Investments’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$465 Buy
+100
New +$377 ﹤0.01% 5318
2025
Q3 		– Sell
-357
Closed -$2.49K – 5599
2025
Q2 		$2.49K Buy
+357
New +$2.17K ﹤0.01% 4832
2022
Q3 		– Sell
-165
Closed -$1K – 5466
2022
Q2 		$1K Buy
165
+39
+31% +$227 ﹤0.01% 4819
2022
Q1 		$1K Buy
+126
New +$1.09K ﹤0.01% 4861

Other funds holding XGN

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Fidelity Investments's XGN Position: Q2 2026 in Review

Fidelity Investments opened a new position in Exagen (XGN) in Q2 2026: 100 shares worth $465. The stake represents ﹤0.01% of the portfolio and ranks #5318 among its holdings. This is a return to the name: Fidelity Investments previously reported a position in XGN as recently as Q2 2025.

Fidelity Investments first reported a position in XGN in Q1 2022 and has held it in 4 quarters since. The position peaked at $2.49K in Q2 2025. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • Fidelity Investments held 100 shares of Exagen worth $465 as of Q2 2026.
  • Exagen was a new Fidelity Investments position in Q2 2026.
  • Exagen made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5318 holding.
  • Fidelity Investments first reported a position in Exagen in Q1 2022 and has held it in 4 quarters since.
  • Fidelity Investments's Exagen position peaked at $2.49K in Q2 2025.
  • 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.